Startups

Lario Therapeutics

Develops precision medicines for epilepsy and other neurological disorders, including Parkinson’s disease, using genetically validated targets and neuronal calcium channel inhibitors.

Team

Chiara LiberatiInvestor Director

Daniel GillCo-founder, Head of Operations & Project Management

Heidrun PotschkaHead of Epilepsy Pharmacology

Henning SteinhagenCo-founder & Advisor

Liz Mortimer-CassenHead of Safety

Paolo PevarelloHead of Chemistry

Peter FinanExecutive Chair, Investor Director, Epidarex

Richard BrooksFinancial Director

Timothy Schulz-UtermoehlHead of DMPK

Tom OtisCSO

Investments

$—Unknown date

Epidarex Capital